55 related articles for article (PubMed ID: 29813017)
21. Development of a CRISPR/Cas9-Based Tool for Gene Deletion in
Tran VG; Cao M; Fatma Z; Song X; Zhao H
mSphere; 2019 Jun; 4(3):. PubMed ID: 31243078
[TBL] [Abstract][Full Text] [Related]
22. Homology-integrated CRISPR-Cas (HI-CRISPR) system for one-step multigene disruption in Saccharomyces cerevisiae.
Bao Z; Xiao H; Liang J; Zhang L; Xiong X; Sun N; Si T; Zhao H
ACS Synth Biol; 2015 May; 4(5):585-94. PubMed ID: 25207793
[TBL] [Abstract][Full Text] [Related]
23. The gal80 Deletion by CRISPR-Cas9 in Engineered Saccharomyces cerevisiae Produces Artemisinic Acid Without Galactose Induction.
Ai L; Guo W; Chen W; Teng Y; Bai L
Curr Microbiol; 2019 Nov; 76(11):1313-1319. PubMed ID: 31392501
[TBL] [Abstract][Full Text] [Related]
24. Optimizing sgRNA structure to improve CRISPR-Cas9 knockout efficiency.
Dang Y; Jia G; Choi J; Ma H; Anaya E; Ye C; Shankar P; Wu H
Genome Biol; 2015 Dec; 16():280. PubMed ID: 26671237
[TBL] [Abstract][Full Text] [Related]
25. An undergraduate laboratory module that uses the CRISPR/Cas9 system to generate frameshift mutations in yeast.
de Waal E; Tran T; Abbondanza D; Dey A; Peterson C
Biochem Mol Biol Educ; 2019 Sep; 47(5):573-580. PubMed ID: 31225941
[TBL] [Abstract][Full Text] [Related]
26. Corrigendum to "Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing"[Anal. Biochem. 568 (2019) 31-40].
Ghassemi B; Ajami M; Shamsara M; Soleimani M; Kiani J; Rassoulzadegan M
Anal Biochem; 2019 Oct; 583():113343. PubMed ID: 31377445
[No Abstract] [Full Text] [Related]
27. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
28. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
[TBL] [Abstract][Full Text] [Related]
29. The promise and peril of CRISPR gene drives: Genetic variation and inbreeding may impede the propagation of gene drives based on the CRISPR genome editing technology.
Zentner GE; Wade MJ
Bioessays; 2017 Oct; 39(10):. PubMed ID: 28863233
[TBL] [Abstract][Full Text] [Related]
30. Construction of a One-Vector Multiplex CRISPR/Cas9 Editing System to Inhibit Nucleopolyhedrovirus Replication in Silkworms.
Dong Z; Qin Q; Hu Z; Chen P; Huang L; Zhang X; Tian T; Lu C; Pan M
Virol Sin; 2019 Aug; 34(4):444-453. PubMed ID: 31218589
[TBL] [Abstract][Full Text] [Related]
31. Putting the brakes on CRISPR-Cas9 gene drive systems.
Graham DM
Lab Anim (NY); 2016 Feb; 45(2):47. PubMed ID: 26814339
[No Abstract] [Full Text] [Related]
32. Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing.
Sun D; Sun Z; Jiang H; Vaidya AM; Xin R; Ayat NR; Schilb AL; Qiao PL; Han Z; Naderi A; Lu ZR
Bioconjug Chem; 2019 Mar; 30(3):667-678. PubMed ID: 30582790
[TBL] [Abstract][Full Text] [Related]
33. Publisher Correction: Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity.
He F; Bhoobalan-Chitty Y; Van LB; Kjeldsen AL; Dedola M; Makarova KS; Koonin EV; Brodersen DE; Peng X
Nat Microbiol; 2018 Sep; 3(9):1076. PubMed ID: 29934592
[TBL] [Abstract][Full Text] [Related]
34. Corrigendum: Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Jul; 164(7):1004. PubMed ID: 29813017
[No Abstract] [Full Text] [Related]
35. Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae.
Basgall EM; Goetting SC; Goeckel ME; Giersch RM; Roggenkamp E; Schrock MN; Halloran M; Finnigan GC
Microbiology (Reading); 2018 Apr; 164(4):464-474. PubMed ID: 29488867
[TBL] [Abstract][Full Text] [Related]
36. Conformational plasticity of SpyCas9 induced by AcrIIA4 and AcrIIA2: Insights from molecular dynamics simulation.
Wen S; Zhao Y; Qi X; Cai M; Huang K; Liu H; Kong DX
Comput Struct Biotechnol J; 2024 Dec; 23():537-548. PubMed ID: 38235361
[TBL] [Abstract][Full Text] [Related]
37. Tuning CRISPR-Cas9 Gene Drives in
Roggenkamp E; Giersch RM; Schrock MN; Turnquist E; Halloran M; Finnigan GC
G3 (Bethesda); 2018 Mar; 8(3):999-1018. PubMed ID: 29348295
[TBL] [Abstract][Full Text] [Related]
38. Yeast Still a Beast: Diverse Applications of CRISPR/Cas Editing Technology in
Giersch RM; Finnigan GC
Yale J Biol Med; 2017 Dec; 90(4):643-651. PubMed ID: 29259528
[TBL] [Abstract][Full Text] [Related]
39. CRISPR system in the yeast Saccharomyces cerevisiae and its application in the bioproduction of useful chemicals.
Mitsui R; Yamada R; Ogino H
World J Microbiol Biotechnol; 2019 Jul; 35(7):111. PubMed ID: 31280424
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
